BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29546615)

  • 21. Risk factors, mortality, and timing of ischemic and hemorrhagic stroke with left ventricular assist devices.
    Frontera JA; Starling R; Cho SM; Nowacki AS; Uchino K; Hussain MS; Mountis M; Moazami N
    J Heart Lung Transplant; 2017 Jun; 36(6):673-683. PubMed ID: 28110971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meta-Analysis of the Relation of Ventricular Arrhythmias to All-Cause Mortality After Implantation of a Left Ventricular Assist Device.
    Makki N; Mesubi O; Steyers C; Olshansky B; Abraham WT
    Am J Cardiol; 2015 Nov; 116(9):1385-90. PubMed ID: 26361826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smoking and the Risk of Stroke in Patients with a Left Ventricular Assist device.
    Sherazi S; Goldenberg I; McNitt S; Kutyifa V; Gosev I; Wood K; Chen L; Polonsky B; Vidula H; Alexis JD
    ASAIO J; 2021 Nov; 67(11):1217-1221. PubMed ID: 34049312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphodiesterase-5 Inhibitors and Outcomes During Left Ventricular Assist Device Support: A Systematic Review and Meta-Analysis.
    Kittipibul V; Blumer V; Angsubhakorn N; Hernandez GA; Chaparro S; Tedford RJ; Agarwal R
    J Card Fail; 2021 Apr; 27(4):477-485. PubMed ID: 33385522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of right ventricular failure after ventricular assist device implant: systematic review and meta-analysis of observational studies.
    Bellavia D; Iacovoni A; Scardulla C; Moja L; Pilato M; Kushwaha SS; Senni M; Clemenza F; Agnese V; Falletta C; Romano G; Maalouf J; Dandel M
    Eur J Heart Fail; 2017 Jul; 19(7):926-946. PubMed ID: 28371221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials.
    Cheng JM; den Uil CA; Hoeks SE; van der Ent M; Jewbali LS; van Domburg RT; Serruys PW
    Eur Heart J; 2009 Sep; 30(17):2102-8. PubMed ID: 19617601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurologic events with a totally implantable left ventricular assist device: European LionHeart Clinical Utility Baseline Study (CUBS).
    Pae WE; Connell JM; Boehmer JP; Korfer R; El-Banayosy A; Hetzer R; Vigano M; Pavie A;
    J Heart Lung Transplant; 2007 Jan; 26(1):1-8. PubMed ID: 17234510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Midterm outcome of implantable left ventricular assist devices as a bridge to transplantation: Single-center experience in Japan.
    Kimura M; Kinoshita O; Nawata K; Nishimura T; Hatano M; Imamura T; Endo M; Kagami Y; Kubo H; Kashiwa K; Kinugawa K; Kyo S; Komuro I; Ono M
    J Cardiol; 2015 May; 65(5):383-9. PubMed ID: 25034705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early Right Ventricular Assist Device Use in Patients Undergoing Continuous-Flow Left Ventricular Assist Device Implantation: Incidence and Risk Factors From the Interagency Registry for Mechanically Assisted Circulatory Support.
    Kiernan MS; Grandin EW; Brinkley M; Kapur NK; Pham DT; Ruthazer R; Rame JE; Atluri P; Birati EY; Oliveira GH; Pagani FD; Kirklin JK; Naftel D; Kormos RL; Teuteberg JJ; DeNofrio D
    Circ Heart Fail; 2017 Oct; 10(10):. PubMed ID: 29021348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk analysis of bloodstream infection during long-term left ventricular assist device support.
    Toda K; Yonemoto Y; Fujita T; Shimahara Y; Sato S; Nakatani T; Kobayashi J
    Ann Thorac Surg; 2012 Nov; 94(5):1387-93. PubMed ID: 22571882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device.
    Kirklin JK; Naftel DC; Kormos RL; Pagani FD; Myers SL; Stevenson LW; Acker MA; Goldstein DL; Silvestry SC; Milano CA; Baldwin JT; Pinney S; Eduardo Rame J; Miller MA
    J Heart Lung Transplant; 2014 Jan; 33(1):12-22. PubMed ID: 24418730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of ventricular arrhythmia after left ventricular assist device implantation: A large single-center observational study.
    Efimova E; Fischer J; Bertagnolli L; Dinov B; Kircher S; Rolf S; Sommer P; Bollmann A; Richter S; Meyer A; Garbade J; Hindricks G; Arya A
    Heart Rhythm; 2017 Dec; 14(12):1812-1819. PubMed ID: 28756099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stroke and Intracranial Hemorrhage in HeartMate II and HeartWare Left Ventricular Assist Devices: A Systematic Review.
    Cho SM; Moazami N; Frontera JA
    Neurocrit Care; 2017 Aug; 27(1):17-25. PubMed ID: 28324260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era.
    Topkara VK; Kondareddy S; Malik F; Wang IW; Mann DL; Ewald GA; Moazami N
    Ann Thorac Surg; 2010 Oct; 90(4):1270-7. PubMed ID: 20868826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antipsychotics and the Risk of Cerebrovascular Accident: A Systematic Review and Meta-Analysis of Observational Studies.
    Hsu WT; Esmaily-Fard A; Lai CC; Zala D; Lee SH; Chang SS; Lee CC
    J Am Med Dir Assoc; 2017 Aug; 18(8):692-699. PubMed ID: 28431909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concomitant tricuspid valve surgery during implantation of continuous-flow left ventricular assist devices: a Society of Thoracic Surgeons database analysis.
    Robertson JO; Grau-Sepulveda MV; Okada S; O'Brien SM; Matthew Brennan J; Shah AS; Itoh A; Damiano RJ; Prasad S; Silvestry SC
    J Heart Lung Transplant; 2014 Jun; 33(6):609-17. PubMed ID: 24661682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients.
    Boyle AJ; Jorde UP; Sun B; Park SJ; Milano CA; Frazier OH; Sundareswaran KS; Farrar DJ; Russell SD;
    J Am Coll Cardiol; 2014 Mar; 63(9):880-8. PubMed ID: 24316083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meta-Analysis of Time in Therapeutic Range in Continuous-Flow Left Ventricular Assist Device Patients Receiving Warfarin.
    Martinez BK; Yik B; Tran R; Ilham S; Coleman CI; Jennings DL; Baker WL
    Artif Organs; 2018 Jul; 42(7):700-704. PubMed ID: 29508409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.